glp 1 meds and hashimoto's GLP-1: what thyroid patients need to know before starting GLP-1 with Hashimoto's Disease: Safety

Currently, hyperuricemia has become the second major metabolic disease in modern society and the prevalence of hyperuricemia among adult males and females was 21.7% and 14.4% respectively

10.1007/s00125-012-2747-2 95 KimS

15,20 Serious GI AEs, though uncommon, have also been reported with GLP-1 RA therapy, including gastroparesis, intestinal obstruction, pancreatitis, and colonic ischemia

This was to help with chronic medical conditions such as mild asthma, fibromyalgia, fatigue, migraines, immune support, jet lag, athletic recovery, better sleep & enhanced overall well being

The resin was then drained and washed with DCM and DMF